Consultation

Scott consults in a broad range of clinical trials and other biostatistical areas. Though a more complete recitation of Scott's participation in advisory panels and boards can be reviewed in Scott's CV, a listing of some recent appointments is provided below (DSMB=Data Safety Monitoring Board):

• Member, FDA Reproductive Drugs Scientific Advisory Panel 2002 - 2006
• Member, DSMB, National Lung Screening Trial, National Cancer Institute
• Member, DSMB, DFMO and Sulindac in Colon Polyp Prevention, University of California Irvine (NCI sponsored)
• Member, DSMB, Clinical Trial of Apheresis Column in Rheumatoid Arthritis, Otsuka Corporation
• Member, DSMB, Clinical Trials of Histamine in Malignant Melanoma and Acute Myelogenous Leukemia, Maxim Pharmaceuticals
• Member, DSMB, LIMIT Trial, Genentech Corporation
• Chair, DSMB, Clinical Trial of anti-CD11 in Psoriasis, Genentech
• Member, DSMB, Clinical Trial of Efalizumab in Rheumatoid Arthritis, Xoma/Genentech
• Member, DSMB, Clinical Trial of Vaccine in Lung Cancer, Biomira
• Chair, DSMB, Clinical Trials of Histamine in Malignant Melanoma, Maxim Pharmaceuticals
• Member, DSMB, Clinical Trials of rTFPI in Severe Community Acquired Pneumonia, Chiron
• Member, DSMB, Clinical Trials of Rituximab in Multiple Sclerosis, Genentech
• Member, DSMB, Clinical Trials in Gastointestinal Stromal Tumors and Metastatic Breast Cancer, Agouron